Camp4 Therapeutics CAMP
NASDAQ CAMP
$3.84 -0.20 (-4.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

Camp4 Therapeutics (CAMP) Return on Equity [ROE] (2025 - 2026)

Updated

Camp4 Therapeutics' Return on Equity [ROE] came in at -331.21% for Q2 2026, down 217.77 percentage points from -113.44% a year earlier and down 203.92 percentage points from the prior quarter.

Analysis

Camp4 Therapeutics (CAMP) Return on Equity [ROE] (2025 - 2026) Analysis & Trends

For FY2025, Camp4 Therapeutics' Return on Equity [ROE] was -90.90%.

  • Business Quant data shows CAMP's Return on Equity [ROE] at -127.29% (Q1 2026), -94.73% (Q4 2025) and -104.89% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Camp4 Therapeutics 209.79 Mn 209.79 Mn - -331.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -331.21%
Mar 31, 2026 -127.29%
Dec 31, 2025 -94.73%
Sep 30, 2025 -104.89%
Jun 30, 2025 -113.44%
Mar 31, 2025 -90.29%
API Access

Camp4 Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CAMP&period=max&api_key=YOUR_API_KEY